dexverapamil
CHEBI:CHEBI_77734
Definition
A 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile that has R configuration. It competitively inhibits the multidrug resistance efflux pump P-glycoprotein (MDR-1, EC 3.6.3.44), thereby potentially increasing the effectiveness of a wide range of antineoplastic drugs which are inactivated by MDR-1 mechanisms. Dexverapamil exhibits lower calcium antagonistic activity and toxicity than racemic verapamil.
Chemical Information
- Molecular Formula
- C27H38N2O4
- Molecular Mass
- 454.60160
- Charge
- 0
- SMILES
- COc1ccc(CCN(C)CCC[C@@](C#N)(C(C)C)c2ccc(OC)c(OC)c2)cc1OC
- InChI
- InChI=1S/C27H38N2O4/c1-20(2)27(19-28,22-10-12-24(31-5)26(18-22)33-7)14-8-15-29(3)16-13-21-9-11-23(30-4)25(17-21)32-6/h9-12,17-18,20H,8,13-16H2,1-7H3/t27-/m1/s1
- InChIKey
- SGTNSNPWRIOYBX-HHHXNRCGSA-N
Alternative Names
- (+)-(2R)-2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile
- (+)-(R)-5-((3,4-dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile
- (+)-(R)-verapamil
- (+)-2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile
- (+)-3-(3,4-dimethoxyphenyl)-6-((5,6-dimethoxyphenethyl)methylamino)hexane-3-carbonitrile
- (+)-verapamil
- (2R)-(+)-2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile
- (2R)-2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile
- (R)-(+)-verapamil
- (R)-verapamil
- dexverapamil
- dexverapamilo
- dexverapamilum
Drug Classification
-
t296665
-
t296823
-
t297030
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- oboInOwl#hasDbXref
- Reaxys:3657914
- core#notation
- CHEBI:77734
Additional References
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- oboInOwl#hasOBONamespace
- chebi_ontology
- oboInOwl#hasDbXref
- Reaxys:3657914
- oboInOwl#id
- CHEBI:77734
- core#notation
- CHEBI:77734
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#3_STAR
- RO_0000087
- http://purl.obolibrary.org/obo/CHEBI_77748
- chebi#is_enantiomer_of
- http://purl.obolibrary.org/obo/CHEBI_77736
- chebi#is_conjugate_base_of
- http://purl.obolibrary.org/obo/CHEBI_77737
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- BFO_0000051
- http://purl.obolibrary.org/obo/CHEBI_9948
- chebi#is_conjugate_acid_of
- http://purl.obolibrary.org/obo/CHEBI_77737
- owl#annotatedSource
- t297147
- owl#someValuesFrom
- t324351